NOF to Exhibit at ARVO 2025 from May 4 – 7

NOF CORPORATION is pleased to announce its participation in the upcoming ARVO 2025 (Association for Research in Vision and Ophthalmology 2025) to be held at the Salt Palace Convention Center, Salt Lake City, UT, USA, from May 4 to 8.

The conference web site: https://www.arvo.org/annual-meeting/

In the event, NOF CORPORATION will feature YT-LIPIDURE® series, its leading product used in eye drops, at booth #1009 from May 4 to 7.

1. YT-LIPIDURE® series

     YT-LIPIDURE® series (MPC*1 polymer), provides the following functions in eye drops.• Dry eye score improvement

                • Protective effect against preservatives
                • Prevention of tear film break-up
                • Stabilization of tear film
                • Moisturizing
                • Possible to apply on wearing hard and soft contact lenses
                • Approved as additives by PMDA*2 in Japan

     *1 MPC：2-methacryloyloxyethylphosphorylcholine
     *2 PMDA：Pharmaceuticals and Medical Devices Agency

For further information or to arrange a meeting, please refer to the contact information below.

    LIPIDURE is a registered trademark or a trademark of NOF CORPORATION in U.S., Japan, EU and several other countries.